SION
Sionna Therapeutics, Inc.
OpenVolumeMkt capP/EEPSDiv yield
Day – 52-wk –
Expected move
InputsNext report
Last report
Largest filed tie
13F top-10 QoQ
Top fund weight
Last reportshaded = implied▲▼ = realized× = |realized| ÷ implied
Sionna Therapeutics, Inc.
3.88
−0.12 · −3.09%
post 3.88 0.00%
No thesis.
Fund move
Fund move
| Rank | Manager | Value | % 13F | ||
|---|---|---|---|---|---|
| 1 | RA Capital ManagementRA Capital Management | $435.7M | 20.52% | 0.00% | |
| 2 | TPG GP ATPG GP A | $285.7M | 13.46% | 0.00% | |
| 3 | Viking Global InvestorsViking Global Investors | $140.6M | 6.62% | 0.00% | |
| 4 | Atlas Venture Life Science AdvisorsAtlas Venture Life Science | $131.8M | 6.21% | 0.00% | |
| 5 | Orbimed AdvisorsOrbimed | $112.4M | 5.30% | −27.61% | |
| 6 | Enavate Sciences GPEnavate Sciences GP | $109.0M | 5.13% | 0.00% | |
| 7 | Adage Capital Partners GPAdage Capital Partners GP | $70.4M | 3.31% | +966.67% | |
| 8 | BlackRockBlackRockindex-like | $64.9M | 3.06% | +13.81% | |
| 9 | JPMorgan ChaseJPMorgan Chase | $64.1M | 3.02% | +1.74% | |
| 10 | Jennison AssociatesJennison | $51.6M | 2.43% | −19.23% | |
| 11 | Citadel AdvisorsCitadel | $50.9M | 2.40% | −0.93% | |
| 12 | Vanguard Capital ManagementVanguardindex-like | $49.8M | 2.35% | +9.96% | |
| 13 | State StreetState Streetindex-like | $44.9M | 2.12% | +35.08% | |
| 14 | Perceptive AdvisorsPerceptive | $39.8M | 1.88% | +37.45% | |
| 15 | Deerfield ManagementDeerfield | $30.0M | 1.41% | −29.85% | |
| 16 | SirenSiren | $26.9M | 1.26% | +103.50% | |
| 17 | T. Rowe Price AssociatesT. Rowe Price | $21.0M | 0.99% | −36.80% | |
| 18 | Eventide Asset ManagementEventide | $20.9M | 0.98% | −26.42% | |
| 19 | Geode Capital ManagementGeodeindex-like | $20.1M | 0.95% | +17.26% | |
| 20 | Baker Bros. AdvisorsBaker Bros. | $17.6M | 0.83% | 0.00% | |
| 21 | Casdin CapitalCasdin Capital | $17.6M | 0.83% | new | |
| 22 | Goldman Sachs GroupGoldman Sachs | $17.1M | 0.81% | +47.74% | |
| 23 | Driehaus Capital ManagementDriehaus | $17.0M | 0.80% | +402.98% | |
| 24 | Millennium ManagementMillennium | $14.3M | 0.67% | +131.32% | |
| 25 | Franklin ResourcesFranklin Resources | $12.8M | 0.60% | +65.32% |
150 managers report $2.1B of Sionna Therapeutics on form 13F for the quarter ended Jun 30 '26. 16 of them hold 80% of it; RA Capital Management is largest at 20.52%.
Linked news
Expected move
No implied move.
No implied move.
No implied move.